TRCT
DBD icon

Tower Research Capital (TRC)’s Diebold Nixdorf DBD Stock Holding History

Tower Research Capital (TRC)’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Buy
1,936
+1,272
+192% +$93.6K ﹤0.01% 1870
2025
Q4 		$45.1K Sell
664
-544
-45% -$34K ﹤0.01% 2502
2025
Q3 		$68.9K Sell
1,208
-3,737
-76% -$221K ﹤0.01% 2275
2025
Q2 		$274K Buy
4,945
+4,441
+881% +$208K 0.01% 1504
2025
Q1 		$22K Buy
504
+217
+76% +$9.46K ﹤0.01% 2868
2024
Q4 		$12.4K Buy
287
+182
+173% +$8.2K ﹤0.01% 3622
2024
Q3 		$4.69K Buy
+105
New +$4.34K ﹤0.01% 4449
2024
Q2 		– Sell
-7,459
Closed -$257K – 5734
2024
Q1 		$257K Buy
7,459
+5,864
+368% +$188K 0.01% 1251
2023
Q4 		$46.2K Buy
+1,595
New +$36.4K ﹤0.01% 3187

Other funds holding DBD

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $254M AUM 16.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Tower Research Capital (TRC)'s DBD Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Diebold Nixdorf (DBD) stake by 192% in Q1 2026, buying an estimated $93.6K and bringing the position to 1,936 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Tower Research Capital (TRC) first reported a position in DBD in Q4 2023 and has held it in 9 quarters since. The position peaked at $274K in Q2 2025. 201 funds tracked by Wall St. Rank hold DBD as of Q1 2026.

  • Tower Research Capital (TRC) held 1,936 shares of Diebold Nixdorf worth $146K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,272 Diebold Nixdorf shares in Q1 2026, an estimated $93.6K.
  • Diebold Nixdorf made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1870 holding.
  • Tower Research Capital (TRC) first reported a position in Diebold Nixdorf in Q4 2023 and has held it in 9 quarters since.
  • Tower Research Capital (TRC)'s Diebold Nixdorf position peaked at $274K in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.